← Back to Search

Integrated Machine Learning Approach for High Cholesterol (BEAT FH Trial)

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial aims to find those at high risk of familial hypercholesterolemia and encourage diagnosis and treatment. Three phases will help make it happen.

Who is the study for?
This trial is for patients at Penn Medicine who are identified by the FIND FH tool as likely having Familial Hypercholesterolemia (FH), but have not been clinically diagnosed with it. It's aimed at those who may be at high risk of this condition, which involves very high cholesterol levels.
What is being tested?
The study tests new ways to find and manage FH using a machine learning tool within electronic health records. It includes refining referral processes for primary care providers and exploring patient outreach methods across three phases: data gathering, pilot development, and a large-scale pragmatic trial.
What are the potential side effects?
Since this trial focuses on diagnosis and management strategies rather than medication or medical procedures, traditional side effects are not applicable. However, there might be indirect consequences related to changes in clinical management practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of actual patient visits with a lipid specialist
Rate of referrals to preventive cardiology

Trial Design

2Treatment groups
Active Control
Group I: Patients with a primary care physician within the UPHS health systemActive Control2 Interventions
Pilot 2 is examining ways to increase physician referrals to preventive cardiology, and increase patient visits with a lipid specialist for a formal evaluation of FH.
Group II: Patients without a primary care physician within the UPHS health systemActive Control1 Intervention
Pilot 1 is examining ways to get patients without a primary care physician within the UPHS health system to schedule a visit with a lipid specialist for a formal evaluation of FH.

Find a Location

Who is running the clinical trial?

Family Heart FoundationUNKNOWN
2 Previous Clinical Trials
822 Total Patients Enrolled
Northwestern UniversityOTHER
1,625 Previous Clinical Trials
937,209 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,013,047 Total Patients Enrolled

Media Library

Patients with a primary care physician within the UPHS health system Clinical Trial Eligibility Overview. Trial Name: NCT05746247 — N/A
High Cholesterol Research Study Groups: Patients with a primary care physician within the UPHS health system, Patients without a primary care physician within the UPHS health system
High Cholesterol Clinical Trial 2023: Patients with a primary care physician within the UPHS health system Highlights & Side Effects. Trial Name: NCT05746247 — N/A
Patients with a primary care physician within the UPHS health system 2023 Treatment Timeline for Medical Study. Trial Name: NCT05746247 — N/A
~0 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top